Cancer drug Keytruda, vaccines propel Merck to quarterly profit beat
July 30, 2019
Oil prices up on expectations of Fed rate cut
July 30, 2019

Mylan reaches $30 million settlement in SEC’s EpiPen probe

Mylan NV has reached a tentative agreement to pay $30 million to resolve a probe by the U.S. Securities and Exchange Commission related to its emergency allergy shot EpiPen, which became the center of a firestorm over price increases.

Powered by WPeMatico